Benzinga's Top #PreMarket Gainers

Halozyme Therapeutics

shares gained 13.86% to $9.20 in pre-market trading after the company reported that it will resume PEGPH20 clinical program in pancreatic cancer. Ciena

jumped 11.69% to $ 21.21 in pre-market trading after the company reported upbeat fiscal second-quarter earnings. Ciena now projected Q3 revenue of $585 million to $615 million. Verint Systems

shares jumped 7.30% to $49.99 in pre-market trading after the company reported upbeat first-quarter results and lifted its full-year forecast. Five Below

soared 2.66% to $37.50 in the pre-market trading after the company reported better-than-expected Q1 earnings.